Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 4

Bloodstream infections in pediatric hematology/oncology patients: Six years’ experience of a single center in Turkey

Pages
1157–1164
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By identifying the causative microorganisms and their antimicrobial resistancepatterns, it will be possible to obtain positive clinical results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Bloodstream infections are the major cause of morbidity, increased cost, prolonged hospitalization, and mortalityin pediatric patients.
📊
Key Findings & Data:We aimed to identify the causative microorganisms and theirantimicrobial susceptibilities in patients with bloodstream infections.Materials and methods: Data belonging to patients with hematological and/or oncological diseases admitted to our hospital with feverbetween January 2010 and November 2015 were analyzed.Results: In total, 71 patients who had 111 bloodstream infection episodes were included.
💡
Conclusion & Impact:By identifying the causative microorganisms and their antimicrobial resistancepatterns, it will be possible to obtain positive clinical results.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Bloodstream infections are the major cause of morbidity, increased cost, prolonged hospitalization, and mortalityin pediatric patients. Identifying the predominant microorganisms and antimicrobial susceptibilities in centers helps to select effectiveempirical antimicrobials which leads to positive clinical outcomes. We aimed to identify the causative microorganisms and theirantimicrobial susceptibilities in patients with bloodstream infections.Materials and methods: Data belonging to patients with hematological and/or oncological diseases admitted to our hospital with feverbetween January 2010 and November 2015 were analyzed.Results: In total, 71 patients who had 111 bloodstream infection episodes were included. Responsible pathogens were detected as follows:35.1% gram-positive microorganisms, 60.5% gram-negative bacteria, and 4.4% fungi. The most common causative gram-negativepathogen was Escherichia coli and the most commonly isolated gram-positive microorganism was coagulase-negative staphylococci.Conclusion: Gram-negative microorganisms were predominant pathogens in bloodstream infections. Escherichia coli and coagulasenegative staphylococci were the most commonly isolated responsible pathogens. Beta-lactam/lactamase inhibitors were suitable forempirical treatment. However, in critical cases, colistin could have been used for empirical treatment until the culture results wereavailable. Routine glycopeptide use was not required. By identifying the causative microorganisms and their antimicrobial resistancepatterns, it will be possible to obtain positive clinical results.

🔖

Cite This Article

İLERİ, T., ERAT, T., YAHŞİ, A., İNCE, E., ÇİFTÇİ, E., KARA, T. T., ÖZDEMİR, H., TAÇYILDIZ, N., ÜNAL, E., İNCE, E. (2022). Bloodstream infections in pediatric hematology/oncology patients: Six years’ experience of a single center in Turkey. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 4, 1157–1164. https://ajindex.com/articles/609939

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Doganis D, Asmar B, Yankelevich M, Thomas R, Ravindranath Y. How many sources should be cultured for the diagnosis of a blood stream infection in children with cancer? Pediatric Hematology and Oncology 2013
  2. 30 (5): 416-424. doi: 10.3109/08880018.2013.783892 2. Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Research Notes 2015
  3. doi: 10.1186/s13104- 015-1701-z 3. Krenn T, Fleischhack G, Moser O, Dilloo D, Bode U et al. Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals. Klinische Pädiatrie 2011
  4. 223 (06): 335-340. doi: 10.1055/s-0031-1287838 4. Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O et al. Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors. Europen Journal of Pediatrics 2015
  5. 174 (5): 675-686. doi: 10.1007/ s00431-015-2525-5 5. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2011
  6. 52 (4): 427-431. doi: 10.1093/cid/ciq147 6. Radhakrishnan V, Vijaykumar V, Ganesan P, Rajendranath R, Trivadi G et al. Bloodstream infections in pediatric patients at cancer institute, Chennai. Indian Journal of Cancer 2014
  7. 51 (4): 418-419. doi: 10.4103/0019-509X.175360 7. Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D et al. Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. Journal of Infection 2014
  8. 68 (4): 321-331. doi: 10.1016/j.jinf.2013 8. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009
  9. 49 (1): 1-45. doi: 10.1086/599376 9. Lv H, Ning B. Pathogenesis of bloodstream infection in children with blood cancer. Experimental and Therapeutic Medicine 2013
  10. 5 (1): 201-204. doi: 10.3892/etm.2012.738 10. Abdul Rasool Hassan B, Yusoff ZB, Bin Othman S. Association of neutropenia onset and s